WinstonWınston
Bioceres Crop Solutions logo

Bioceres Crop Solutions

BIOX
19
Agricultural Inputs · Basic Materials
Price
$0.35
+0.00 (+0.40%)
Market Cap
$22.1M
Winston Score
19
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+61.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 39.2M (2021) → 63.2M (2025)

Bioceres Crop Solutions is an agricultural technology company that helps farmers grow more crops using biology instead of chemicals. Its main products include HB4, a drought-tolerant seed trait for wheat and soybeans, along with biostimulants, biofertilizers, and crop protection products. The company sells to farmers and agricultural businesses primarily in Latin America, with a strong base in Argentina.

Bioceres earns revenue by selling its seed treatments, biological inputs, and licensing its HB4 technology to seed companies in exchange for royalty fees. It operates mainly across South America, with growing efforts to expand HB4 licensing into North America and other markets. The company's main competitive edge is its proprietary drought-tolerance technology, which is one of the few commercially approved traits of its kind for wheat globally. The key growth driver is broader regulatory approval and adoption of HB4 wheat, but the business currently runs at a small operating loss, which means execution risk remains meaningful.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-35.9% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-576.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$15M/ year

Declining (-13% vs prior year)

4.5% of revenue

In line with sector average (3%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

29.9%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Position

Cash flow positive

$14M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Bioceres Crop Solutions's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
30.1%
Modest — 30.1% gross margin
Operating Margin
-17.0%
Losing money on operations — -17.0%
ROCE
-2.2%
Weak — -2.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-36.1%
Shrinking sales (-36.1% YoY)
EPS YoY
-59476.2%
Earnings shrinking (-59476.2% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
18.0%
Converts sales into free cash efficiently (18.0%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
3.42
Heavy debt load (3.42)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial